| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |